NEW YORK, April 7 (GenomeWeb News) – The European Union’s Newmood project launched this week at the Human Genome meeting in Berlin, Germany, according to news reports.
Newmood is a five-year project funded under the EC’s 6th Framework with €7.3 million ($8.3M US) bringing together 13 laboratories over 10 countries to investigate the genetics of depression with the aim of developing new drug targets and to aid in the diagnosis.
According to a report published online today by Nature , researchers in the project will build an array of 800 genes that may be related to depression, including those affecting metabolism, growth and cell communication. The chip will detect which genes are active in healthy and depressed animals and humans.
Bill Deakin of the Neuroscience and Psychiatry unit of Manchester University (UK) is the project coordinator.